Indolent Systemic Mastocytosis — Trials

Indolent Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04655118	Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis	unknown	Phase 2	121	Telios Pharma, Inc.INDUSTRY	13	May 10, 2024	clinicaltrials
NCT05923372	Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis(DALY-MAST)	unknown	—	160	University Hospital, ToulouseOTHER	1	Jul 12, 2023	clinicaltrials
NCT04333108	Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment	unknown	Phase 3	140	AB ScienceINDUSTRY	8	May 6, 2023	clinicaltrials
NCT01920204	Midostaurin in Indolent Systemic Mastocytosis

Data updated 22 days agoSource updated May 10, 2024source: clinicaltrials